Number of the records: 1
karbidopa
SYS d002230 LBL 00000cz--a2200000o--4500 005 20250606213602.1 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.092.311.200.538.200 065 $a D02.442.200 065 $a D02.455.426.559.389.657.166.175.200.538.200 066 $a 01 $c 03 150 $a karbidopa $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Methyldopahydrazine $2 eng 450 $w v $a metyldopahydrazín $2 slo 550 $7 sllk_us_auth*d000978 $Y Antiparkinson Agents $w P $a antiparkinsoniká 550 $7 sllk_us_auth*d015259 $Y Dopamine Agents $w P $a látky dopamínové 550 $7 sllk_us_auth*d065105 $Y Aromatic Amino Acid Decarboxylase Inhibitors $w P $a inhibítory dekarboxylázy aromatických aminokyselín 665 $a 80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79; was METHYLDOPAHYDRAZINE 1973-74 (Prov) $2 eng 665 $a Dopa (1972-1974) $2 eng 665 $a Hydrazines (1972-1974) $2 eng 665 $a Methyldopa (1972-1974) $2 eng 680 9-
$i An inhibitor of DOPA DECARBOXYLASE that prevents conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no anti-parkinson activity by itself. $2 eng 750 -2
$a Carbidopa $2 eng 980 $x M
Number of the records: 1